Nature Communications (Feb 2021)

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

  • Q. Sue Huang,
  • Tim Wood,
  • Lauren Jelley,
  • Tineke Jennings,
  • Sarah Jefferies,
  • Karen Daniells,
  • Annette Nesdale,
  • Tony Dowell,
  • Nikki Turner,
  • Priscilla Campbell-Stokes,
  • Michelle Balm,
  • Hazel C. Dobinson,
  • Cameron C. Grant,
  • Shelley James,
  • Nayyereh Aminisani,
  • Jacqui Ralston,
  • Wendy Gunn,
  • Judy Bocacao,
  • Jessica Danielewicz,
  • Tessa Moncrieff,
  • Andrea McNeill,
  • Liza Lopez,
  • Ben Waite,
  • Tomasz Kiedrzynski,
  • Hannah Schrader,
  • Rebekah Gray,
  • Kayla Cook,
  • Danielle Currin,
  • Chaune Engelbrecht,
  • Whitney Tapurau,
  • Leigh Emmerton,
  • Maxine Martin,
  • Michael G. Baker,
  • Susan Taylor,
  • Adrian Trenholme,
  • Conroy Wong,
  • Shirley Lawrence,
  • Colin McArthur,
  • Alicia Stanley,
  • Sally Roberts,
  • Fahimeh Rahnama,
  • Jenny Bennett,
  • Chris Mansell,
  • Meik Dilcher,
  • Anja Werno,
  • Jennifer Grant,
  • Antje van der Linden,
  • Ben Youngblood,
  • Paul G. Thomas,
  • NPIsImpactOnFlu Consortium,
  • Richard J. Webby

DOI
https://doi.org/10.1038/s41467-021-21157-9
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 7

Abstract

Read online

New Zealand has been relatively successful in controlling COVID-19 due to implementation of strict non-pharmaceutical interventions. Here, the authors demonstrate a striking decline in reports of influenza and other non-influenza respiratory pathogens over winter months in which the interventions have been in place.